Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
RPGLIFE
₹2,861.10
₹2613.10
₹2889.00
₹1733.00
₹2715.20
Markets Today
Historical Performance
As of 10-07-2026 23:15, RPG Life Sciences Ltd. share price today is ₹0, with a change of ₹-2656.80 (-100.00%) from the previous close of ₹2656.8. The stock opened at ₹2652.5 and traded between ₹2613.1 and ₹2889, with a total traded volume of 196584 shares. The company has a market capitalization of ₹4394.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2715.2 and ₹1733, respectively.
RPG Life Sciences Ltd. valuation metrics include a P/E ratio of 38.2, EPS of ₹69.64, and book value of ₹7.30. Profitability indicators show ROE of 19.02% along with a dividend yield of 0.9%. RPG Life Sciences Ltd. has reported revenue of ₹707.52 Cr and net profit of ₹115.17 Cr.
RPG Life Sciences Ltd. technical indicators include Day RSI at 81.46, Day MFI at 91.25, Day ADX at 32.41. Additional indicators include Commodity Channel Index (CCI) at 208.2 and Williams %R at -3.83. Momentum indicators show Day MACD at 75.16, Day MACD Signal Line at 47.49, DayATR at 102.79. Rate of Change indicators for RPG Life Sciences Ltd. include ROC125 at 14.89 and ROC21 at 25.49.
Exponential moving averages include EMA5 at ₹2497.6, EMA10 at ₹2429.4, EMA12 at ₹2411.2, EMA20 at ₹2361.4, EMA26 at ₹2336.1, EMA50 at ₹2265.6, EMA100 at ₹2203.7, EMA200 at ₹2190.8. Simple moving averages include SMA5 at ₹2476.3, SMA10 at ₹2397.5, SMA20 at ₹2338.3, SMA30 at ₹2280.7, SMA50 at ₹2289.7, SMA100 at ₹2102.2, SMA150 at ₹2144.2, SMA200 at ₹2191.8.
Support levels for RPG Life Sciences are placed at First Support ₹2457.40, Second Support ₹2258.00, Third Support ₹2149.20. Resistance levels are seen at First Resistance ₹2765.60, Second Resistance ₹2874.40, Third Resistance ₹3073.80. RPG Life Sciences Ltd. shareholding pattern shows promoter holding at 72.95%, FII holding at 0.87%, DII holding at 0%, public holding at 18.72%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 176.89 | 180.03 | 181.68 | 168.92 | 143.09 |
| Operating Expense | 144.02 | 140.27 | 142.65 | 133.45 | 117.60 |
| Operating Profit | 32.87 | 39.76 | 39.03 | 35.47 | 25.49 |
| Depreciation | 5.74 | 5.38 | 5.22 | 5.14 | 5.37 |
| Interest | 0.39 | 0.25 | 0.12 | 0.13 | 0.18 |
| Tax | 10.30 | 6.99 | 12.60 | 9.14 | 17.55 |
| Net Profit | 29.90 | 22.13 | 36.85 | 26.29 | 117.35 |
₹2861.10
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 73 | 73 | 73 | 73 | 73 | 73 |
| FII | 1.3 | 1.5 | 1.4 | 1.1 | 1 | 0.9 |
| DII | 6.1 | 6.1 | 6.4 | 6.7 | 7 | 7.4 |
| Public | 19.7 | 19.5 | 19.2 | 19.2 | 19 | 18.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 40.25 K | 89.36 K | 45.04% |
| Week | 14.77 K | 39.97 K | 36.96% |
| 1 Month | 8.09 K | 22.76 K | 35.53% |
| 6 Month | 8.54 K | 31.7 K | 26.94% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Expensive Rockets (DVM)
Relative Outperformance versus Industry over 1 Month
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Companies with Zero Promoter Pledge
Near 52 Week High
Stock gained more than 20% in one month
High Volume, High Gain
Biggest Price Gainers from Open
Top Gainers
High Volume, High Gain
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 09 Jul, 2026 | 24 | FINAL | 09 Jul, 2026 | Equity Share |
| 27 Jun, 2025 | 4 | SPECIAL | 27 Jun, 2025 | Equity Share |
| 27 Jun, 2025 | 20 | FINAL | 27 Jun, 2025 | Equity Share |
| 28 Jun, 2024 | 16 | FINAL | 28 Jun, 2024 | Equity Share |
| 21 Jul, 2023 | 12 | FINAL | 21 Jul, 2023 | Equity Share |
| 14 Jul, 2022 | 9.6 | FINAL | 15 Jul, 2022 | Equity Share |
| 13 Aug, 2021 | 7.2 | FINAL | 17 Aug, 2021 | Equity Share |
| 24 Mar, 2020 | 4 | INTERIM | 26 Mar, 2020 | Equity Share |
| 22 Jul, 2019 | 2.4 | FINAL | Equity Share | |
| 19 Jul, 2018 | 2.4 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹587.60 | ₹5.40 | ₹179.17 | ₹15.60 | ₹535 | ₹62 |
| % Change | -1.43% | -0.18% | -2.00% | 0.84% | -0.10% | -0.26% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | -1.30 | 47.70 | 29.60 | 26.70 | -103.00 |
| 1 Year Return | 52.07 | 441 | 45.1 | 70 | -25.38 | -41.91 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Solara Active Pharma Sciences Ltd.
₹ 568.90
+0.36%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Dishman Carbogen Amcis Ltd.
₹ 195.49
+1.38%
Lasa Supergenerics Ltd.
₹ 7.52
+1.21%
Advanced Enzyme Technologies Ltd.
₹ 330.00
+1.74%
Bajaj Healthcare Ltd.
₹ 345.50
-1.31%
Ortin Global Ltd.
₹ 16.50
+1.10%
Brooks Laboratories Ltd.
₹ 69.90
-0.87%
Bafna Pharmaceuticals Ltd.
₹ 204.61
+2.00%
Alpa Laboratories Ltd.
₹ 68.70
+0.60%
SMS Pharmaceuticals Ltd.
₹ 403.00
-0.99%
Nectar Lifesciences Ltd.
₹ 11.21
-0.18%
Mangalam Drugs and Organics Ltd.
₹ 27.75
+1.80%
Indoco Remedies Ltd.
₹ 259.00
+1.53%
Ind-Swift Laboratories Ltd.
₹ 247.05
+4.87%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
+0.01%
Panacea Biotec Ltd.
₹ 546.00
-1.66%
Medicamen Biotech Ltd.
₹ 244.00
-0.57%
Themis Medicare Ltd.
₹ 117.59
+1.33%
By signing up I certify terms, conditions & privacy policy